Rulemaking Information

File written comments before 4:30PM on 11/25/2025 by emailing your comments to pharmacy.rulemaking@bop.oregon.gov.

November 25, 2025 Rulemaking Hearing 

• Divs 041/115 - OHA Standing Order Prescription 
  
• Div 104 - Criminal Conviction Determination Process
  

The Board permanently adopted the following rules at the October 2025 board meeting:

• Div 110 - Licensee & Registrant Fee Increase 
  

September 17, 2025 Temporary Rule Noticed

• Div 115 - Standard Vaccination Protocols *Effective 9/17/2025
  
• Standard Vaccination Protocol for Adults 18 Years of Age and Older & Assessment and Treatment Care Pathway
  
• Standard Vaccination Protocol for Persons 7 through 17 Years of Age & Assessment and Treatment Care Pathway
  
• REPEALED - Standard Vaccination Protocol for Persons 3 through 6 Years of Age & Assessment and Treatment Care Pathway 
  
• REPEALED - Standard Vaccination Protocol for Persons 6 Months through 2 Years of Age & Assessment and Treatment Care Pathway
  
• Coronavirus 19 
  
• Influenza 
  
• Respiratory Syncytial Virus 
  
• Div 102 - Board Delegated Limited Authority for Vaccine Protocol rules  *Effective 9/17/2025
  

September 17, 2025 Temporary Rule Suspended 

• Div 115 - Standard Vaccination Protocols
  

August 29, 2025 Temporary Rule Noticed

• Div 115 - Standard Vaccination Protocols *Effective 8/29/2025
• Standard Vaccination Protocol for Adults 18 Years of Age and Older & Assessment and Treatment Care Pathway
  
• Standard Vaccination Protocol for Persons 7 through 17 Years of Age & Assessment and Treatment Care Pathway

August 29, 2025 2025 Temporary Rule Suspended

• Div 115 - Standard Vaccination Protocols 
  
  

August 13, 2025 Temporary Rule Noticed

• Div 115 - Standard Vaccination Protocols  *Effective 8/13/2025
• Standard Vaccination Protocol for Adults 18 Years of Age and Older & Assessment and Treatment Care Pathway
  
• Standard Vaccination Protocol for Persons 7 through 17 Years of Age & Assessment and Treatment Care Pathway
  
• Standard Vaccination Protocol for Persons 3 through 6 Years of Age & Assessment and Treatment Care Pathway
  
• Standard Vaccination Protocol for Persons 6 Months through 2 Years of Age & Assessment and Treatment Care Pathway

The Board permanently adopted the following rules at the August 2025 board meeting:

• Div 102 - Board Delegated Limited Authority for Vaccine Protocol rules  *Effective 8/8/2025
  
• Divs 104/115 - Standard Vaccination Protocols  *Effective 8/8/2025 
  
• Standard Vaccination Protocol for Adults 18 Years of Age and Older & Assessment and Treatment Care Pathway 
  
• Standard Vaccination Protocol for Persons 7 through 17 Years of Age & Assessment and Treatment Care Pathway
  
• Standard Vaccination Protocol for Persons 3 through 6 Years of Age & Assessment and Treatment Care Pathway
  
• Standard Vaccination Protocol for Persons 6 Months through 2 Years of Age & Assessment and Treatment Care Pathway
  
• Standard Vaccination Protocol for Managing Adverse Reactions & Assessment and Treatment Care Pathway
• Divs 115/135 - Standards Adopted by Reference  *Effective 8/8/2025

July 16, 2025 Temporary Rule Noticed 

• Div 110 - Licensee & Registrant Fee Increase  *Effective 7/16/2025 

August 21, 2025 Rulemaking Hearing

• Div 110 - Licensee & Registrant Fee Increase 
  

July 22, 2025 Rulemaking Hearing

• Div 102 - Board Delegated Authority - Amendment of Vaccine Protocol Rules to Adopt ACIP Recommendations 
  
• Divs 104/115 - Standard Vaccination Protocols
  
• Vaccination Protocol for Adults 18 Years of Age and Older
  
• Vaccination Protocol for Adults 18 Years of Age and Older - Assessment and Treatment Care Pathway 
  
• Vaccination Protocol for Ages 7 through 17 Years 
  
• Vaccination Protocol for Ages 7 through 17 Years - Assessment and Treatment Care Pathway
  
• Vaccination Protocol for Ages 3 through 6 Years 
  
• Vaccination Protocol for Ages 3 through 6 Years - Assessment and Treatment Care Pathway 
  
• Vaccination Protocol for Ages 6 Months through 2 Years 
  
• Vaccination Protocol for Ages 6 Months through 2 Years - Assessment and Treatment Care Pathway
  
• Vaccination Protocol for Managing Adverse Reactions
  
• Vaccination Protocol for Managing Adverse Reactions - Assessment and Treatment Care Pathway 
  
• Divs 115/135 - Standards Adopted by Reference 
  

The board permanently adopted the following rules at the June 2025 board meeting: 

• Divs 006/041/043/080/115/120/139/141 - Standards Adopted by Reference  *Effective 6/16/2025
  
• Div 115 - Pharmacists - Services: Prescribing - Protocol Compendium  *Effective 6/13/2025
  
• Vulvovaginal candidiasis (VVC) *Permanently REPEALED 
  
• Contraception v. 06/2025
  
• Coronavirus 2019 v. 06/2025
• Hepatitis B containing vaccines v. 06/2025
  
• Meningococcal containing vaccines v. 06/2025
  
• Pneumococcal v. 06/2025
  
• Respiratory Syncytial Virus  v. 06/2025
  

May 22, 2025 Rulemaking Hearing

• Div 115 - Pharmacists - Services: Prescribing - Protocol Compendium
• Vulvovaginal candidiasis (VVC) *REPEAL 
• Contraception  v. 06/2025
  
• Coronavirus 2019  v. 06/2025
• Hepatitis B containing vaccines  v. 06/2025
• Meningococcal containing vaccines  v. 06/2025
• Pneumococcal  v. 06/2025
• Respiratory Syncytial Virus  v. 06/2025 
  
• Divs 006/041/043/080/115/120/139/141 - Standards Adopted by Reference
  

• May 22, 2025 
  
• July 22, 2025
  
• August 21, 2025
  
• November 25, 2025
  

2024 Proposed & Adopted Rules 

December 17, 2024 Temporary Rule Noticed

• Div 115 - Pharmacists - Services: Prescribing - Protocol Compendium *Effective 12/17/2024
  
• Contraception (v. 12/2024)
  
• Coronavirus 19 (v. 12/17/2024) 
  
• Hepatitis B containing vaccines (v. 12/2024) 
  
• Meningococcal containing vaccines (v. 12/2024)
  
• Pneumococcal (v. 12/2024) 
  
• Respiratory Syncytial Virus (v. 12/17/2024) 
  
• Vulvovaginal Candidiasis (VVC) *REPEAL 
  

December 2024

The board permanently adopted the following rules at the December 2024 Board Meeting: 

• Div 035 - Operation of Nonprescription and Medical Device, Equipment and Gas Outlets - Registration Requirements *Effective 12/17/2024
  
• Div 115 - Pharmacists - Services: Prescribing - Protocol Compendium *Effective 12/17/2024
  
• Coronavirus 19 (v. 12/2024)
• Influenza Inactivated Influenza Vaccines and Recombinant Influenza Vaccines 2024-2025 ( v. 12/2024)
• Influenza Live Attenuated Influenza Vaccine 2024-2025 (v. 12/2024)
• Respiratory Syncytial Virus (v. 12/2024) 
  

November 26, 2024 Rulemaking Hearing

• Div 035 - Operation of Nonprescription and Medical Device, Equipment and Gas Outlets - Registration Requirements
  
• Div 115 - Pharmacists - Services: Prescribing - Protocol Compendium 
  
• Coronavirus 19 (v. 12/2024)
• Influenza Inactivated Influenza Vaccines and Recombinant Influenza Vaccines 2024-2025 (v. 12/2024)
• Influenza Live Attenuated Influenza Vaccine 2024-2025 (v. 12/2024)
• Respiratory Syncytial Virus (v. 12/2024)

October 11, 2024 Temporary Rule Noticed

• OAR 855-035-0005 - Operation of Nonprescription and Medical Device, Equipment and Gas Outlets - Registration Requirements *Effective 10/11/2024 
  

August 9, 2024 Temporary Rule Noticed

• OAR 855-115-0345 Pharmacists - Services: Prescribing - Protocol Compendium *Effective 8/9/2024
  
• Coronavirus 19 (v. 08/2024) 
  
• Influenza Inactivated Influenza Vaccines and Recombinant Influenza Vaccines 2024-2025 (v. 08/2024)
  
• Influenza Live Attenuated Influenza Vaccine 2024-2025 (v. 08/2024)
  
• Respiratory Syncytial Virus (v. 08/2024)
  

August 2024

The board permanently adopted the following rules at the August 2024 Board Meeting:

• Div 115 - Pharmacists - Services: Prescribing - Protocol Compendium *Effective 8/9/2024
  
• Continuation of Therapy including Emergency refills of insulin and early refills of opioid use disorder medications (v. 08/2024)
  
• SARS-CoV-2 Antiviral (v. 08/2024)
  
• Div 135 - Continuing Pharmacy Education - Definitions & General Requirements *Effective 8/9/2024
  
• Div 139 - Remote Dispensing Site Pharmacy - Outlet: General Requirements *Effective 8/9/2024
  

July 23, 2024 Rulemaking Hearing

• Div 115 - Pharmacists - Services: Prescribing - Protocol Compendium
  
• Continuation of Therapy including Emergency refills of insulin and early refills of opioid use disorder medications (v. 08/2024)
• SARS-CoV-2 Antiviral (v. 08/2024)
  
• 2024 HB 4002
  
• 2024 SB 1506
  
• Coronavirus 2019 (v.08/2024) 
  
• Div 135 - Continuing Pharmacy Education - Definitions & General Requirements - Veterinary 
  
• Div 139 - Remote Dispensing Site Pharmacy - Outlet: General Requirements - Mileage 
  
• REVISED NOTICE - Div 139 - Remote Dispensing Site Pharmacy - Outlet: General Requirements - Mileage 
  

June 2024

The board permanently adopted the following rules at the June 2024 Board Meeting:

• Div 115 - Pharmacists - PIC Qualifications & Limitations *REPEAL *Effective 6/20/2024
  
• Div 115 - Pharmacists - Services: Prescribing - Formulary & Protocol Compendium *Effective 6/20/2024
  
• Formulary Devices and Supplies
  
• Continuation of Therapy including Emergency Refills of Insulin
  
• Pseudoephedrine (v. 06/2021) *REPEAL *Effective 6/20/2024 
  
• Tobacco Cessation 
  
• Travel Medications 
  
• Sexually Transmitted Infections Post-exposure Prophylaxis (STI PEP) 
  
• Short-acting Opioid Antagonists 
  
• Standard Protocol for All Vaccines: Cover Page & Assessment and Treatment Care Pathway 
  
• Standard Protocol for All Vaccines: Managing Adverse Reactions 
  
• Coronavirus 19 
  
• Haemophilus Influenzae type b  
  
• Influenza Inactivated Influenza Vaccines and Recombinant Influenza Vaccines 2023-2024 
  
• Japanese Encephalitis 
  
• Meningococcal containing vaccines 
  
• Pneumococcal 
  
• Polio 
  
• Respiratory Syncytial Virus 
  
• Tetanus, Diphtheria containing vaccines
  
• Yellow Fever 
  
  
  
• Div 115 - Pharmacists – Services: Prescribing Practices – Short-acting Opioid Antagonists *Effective 6/20/2024
  
• Div 120 - Interns & Preceptors – Prohibited Practices *Effective 6/20/2024
  
• Div 020 - Pharmacist Prescriptive Authority – Protocol Compendium *REPEAL *Effective 6/20/2024
  
• Div 006/041/043/045/080/115/120/135/139/141 - Standards Adopted by Reference *Effective 6/20/2024
  
• Div 115 - Pharmacists - Responsibilities: Outlet - Delegation of Final Verification *Effective 6/20/2024
  

May 22, 2024 Rulemaking Hearing

• Div 115 - Pharmacists - PIC Qualifications & Limitations *REPEAL 
  
• Div 115 - Pharmacists - Services: Prescribing - Formulary & Protocol Compendium 
  
• Formulary Devices and Supplies
  
• Continuation of Therapy (v. 06/2024)
  
• Pseudoephedrine (v. 06/2021) *REPEAL
  
• Tobacco Cessation (v. 06/2024)
  
• Travel Medications (v. 06/2024)
• Sexually Transmitted Infections Post-exposure Prophylaxis (STI PEP) (v. 06/2024)
• Short-acting Opioid Antagonists (v. 06/2024)
• Standard Protocol for All Vaccines: Cover Page & Assessment and Treatment Care Pathway (v. 06/2024)
• Standard Protocol for All Vaccines: Managing Adverse Reactions (v. 06/2024)
• Coronavirus 19 (v. 06/2024)
• Haemophilus Influenzae type b  (v. 06/2024)
• Influenza Inactivated Influenza Vaccines and Recombinant Influenza Vaccines 2023-2024 (v. 06/2024)
• Japanese Encephalitis (v. 06/2024)
• Meningococcal containing vaccines (v. 06/2024)
• Pneumococcal (v. 06/2024)
• Polio (v. 06/2024)
• Respiratory Syncytial Virus (v. 06/2024)
  
• Tetanus, Diphtheria containing vaccines (v. 06/2024)
• Yellow Fever (v. 06/2024)
  
• Div 115 – Pharmacists – Services: Prescribing Practices – Short-acting Opioid Antagonists 
  
• Div 120 – Interns & Preceptors – Prohibited Practices
  
• Div 020 – Pharmacist Prescriptive Authority – Protocol Compendium *REPEAL
  
• Div 006/041/043/045/080/115/120/135/139/141 – Standards Adopted by Reference
• Div 115 - Pharmacists - Responsibilities: Outlet - Delegation of Final Verification 
  
  

March 4, 2024 Temporary Rule Noticed

• OAR 855-115-0345 Pharmacist- Services: Prescribing - Protocol Compendium - Vaccines - Coronavirus 19  *Effective 3/4/2024 
• Coronavirus 19 
  

March 2024 Temporary Rule Noticed

• OAR 855-115-0345 Pharmacist- Services: Prescribing - Protocol Compendium - Vaccines *Effective 3/1/2024
  

March 2024

The board permanently repealed the following rules at the Special February 23, 2024 Board Meeting:

• OAR 855-019-0270, OAR 855-019-0280, OAR 855-019-0290 and OAR 855-025-0024 related to Pharmacist/COPT/PT Administration of Vaccines  *Effective 2/29/2024
  

The board permanently adopted the following rule at the February 2024 Board Meeting:

• OAR 855-115-0150 Pharmacist- Prohibited Practices *Effective 3/1/2024
  

February 2024 Temporary Rule Noticed 

• Division 020 related to Temporary Suspension of Pharmacist Prescriptive Authority - Protocol Compendium *Effective 2/29/2024
  

February 2024

The board permanently adopted the following rules at the February 2024 Board Meeting:

• Division 001 related to Procedural Rules - Repeal  *Effective 2/29/2024
  
• Division 006 related to Definitions  *Effective 3/1/2024
  
• Division 010 related to Board Administration & Policies - Repeal  *Effective 2/29/2024
  
• Division 019 related to Pharmacists - Repeal  *Effective 2/29/2024
  
• Division 020 related to Pharmacist Prescriptive Authority - Repeal  *Effective 2/29/2024
  
• Division 025 related to Pharmacy Technicians - Repeal  *Effective 2/29/2024
  
• Division 031 related to Interns - Repeal  *Effective 2/29/2024 
  
• Divisions 041/110 related to Consulting Drugless Pharmacies  *Effective 2/29/2024 
  
• Division 041 related to Institutional Drug Outlet Labeling Requirements for Short-acting Opioid Antagonists *Effective 2/15/2024
  
• Division 115 related to Pharmacists - Applicability  *Effective 3/1/2024
  
• Division 115 related to Pharmacists - Collaborative Drug Therapy Management (CDTM)  *Effective 3/1/2024
  
• Division 120 related to Preceptor License Renewal or Reinstatement  *Effective 3/1/2024
  

February 22, 2024 Rulemaking Hearing

• OAR 855-019-0270, OAR 855-019-0280, OAR 855-019-0290 and OAR 855-025-0024 related to Pharmacist/COPT/PT Administration of Vaccines *REPEAL
  

January 24, 2024 Rulemaking Hearing

• Division 001 related to Procedural Rules *REPEAL
  
• Division 006 related to Definitions 
  
• Division 010 related to Board Administration and Policies *REPEAL 
  
• Division 019 related to Pharmacists *REPEAL 
  
• Division 020 related to Pharmacist Prescriptive Authority *REPEAL 
  
• Division 025 related to Pharmacy Technicians *REPEAL 
  
• Division 031 related to Interns *REPEAL 
  
• Divisions 041/110 related to Consulting Drugless Pharmacies *Rule Amendments and REPEAL
  
• Division 041 related to Institutional Drug Outlet Labeling Requirements for Short-acting Opioid Antagonists
  
• Division 115 related to Pharmacists - Applicability
  
• Division 115 related to Pharmacists - Collaborative Drug Therapy Management (CDTM)
  
• Division 115 related to Pharmacists - Prohibited Practices
  
• Division 120 related to Preceptor License Renewal or Reinstatement 
  

2023 Proposed & Adopted Rules 

December 2023 Temporary Rule Noticed

• Division 041 related to Institutional Drug Outlet Labeling for Short-acting Opioid Antagonist  *Effective 1/1/2024 
  

December 2023

The board permanently adopted the following rules at the December 2023 Board Meeting:

• Divisions 019/025/041/139 related to Pharmacist/COPT/PT Administration of Vaccines *Effective 1/1/2024
  
• Division 020 related to Vaccination Protocols - Protocol Compendium *Effective 2/1/2024
  
• Standard Protocol for All Vaccines: Cover Page & Assessment and Treatment Care Pathway (v. 2/2024)
  
• Standard Protocol for All Vaccines: Managing Adverse Reactions (v. 2/2024)
  
• Cholera (v. 2/2024)
  
• Coronavirus 19 (v. 2/2024)
  
• Haemophilus Influenzae type b (v. 2/2024)
  
• Hepatitis A containing vaccines (v. 2/2024)
  
• Hepatitis B containing vaccines (v. 2/2024)
  
• Human Papillomavirus (v. 2/2024) 
  
• Influenza Inactivated Influenza Vaccines and Recombinant Influenza Vaccines 2023-2024 (v. 2/2024)
  
• Influenza Live Attenuated Influenza Vaccine 2023-2024 (v. 2/2024) 
• Japanese Encephalitis (v. 2/2024) 
  
• Measles, Mumps & Rubella containing vaccines (v. 2/2024) 
• Meningococcal containing vaccines (v. 2/2024) 
  
• Pneumococcal (v. 2/2024) 
  
• Polio (v. 2/2024) 
  
• Rabies (v. 2/2024)
• Respiratory Syncytial Virus (v. 2/2024)
  
• Tetanus, Diphtheria containing vaccines (v. 2/2024) 
  
• Typhoid (v. 2/2024) 
  
• Varicella containing vaccines (v. 2/2024) 
  
• Yellow Fever (v. 2/2024) 
• Zoster (v. 2/2024) 
  
• Division 041 related to Drug Outlet Pharmacy Requirements: Personnel, General, Non-Resident, Prescription, Laboratory, & Prescription Transfers *Effective 3/1/2024
  
• Division 080 related to Schedule II Prescriptions *Effective 12/19/2023
  
• Divisions 115/125 related to Pharmacist/COPT/PT Administration of Vaccines *Effective 3/1/2024
  
• Division 115 related to Pharmacist Supervision, Counseling, PIC: Qualifications & Limitations *Effective 3/1/2024
  
• Division 125 related to Pharmacy Technician Prohibited Practices *Effective 3/1/2024 
  

November 21, 2023 Rulemaking Hearing

• Divisions 019/025/041/139 related to Pharmacist/COPT/PT Administration of Vaccines
• Division 020 related to Vaccination Protocols - Protocol Compendium 
  
• Standard Protocol for All Vaccines: Cover Page & Assessment and Treatment Care Pathway (v. 10/2023)
  
• Standard Protocol for All Vaccines: Managing Adverse Reactions (v. 10/2023)
  
• Cholera (v. 10/2023)
  
• Coronavirus 19 (v. 10/2023)
  
• Haemophilus Influenzae type b (v. 10/2023)
  
• Hepatitis A containing vaccines (v. 10/2023)
  
• Hepatitis B containing vaccines (v. 10/2023)
  
• Human Papillomavirus (v. 10/2023) 
• Influenza Inactivated Influenza Vaccines and Recombinant Influenza Vaccines 2023-2024 (v. 10/2023)
  
• Influenza Live Attenuated Influenza Vaccine 2023-2024 (v. 10/2023) 
  
• Japanese Encephalitis (v. 10/2023) 
  
• Measles, Mumps & Rubella containing vaccines (v. 10/2023) 
  
• Meningococcal containing vaccines (v. 10/2023) 
  
• Pneumococcal (v. 10/2023) 
  
• Polio (v. 10/2023) 
  
• Rabies (v. 10/2023) 
  
• Respiratory Syncytial Virus (v. 10/2023)
  
• Tetanus, Diphtheria containing vaccines (v. 10/2023) 
  
• Typhoid (v. 10/2023) 
  
• Varicella containing vaccines (v. 10/2023) 
  
• Yellow Fever (v. 10/2023) 
  
• Zoster (v. 10/2023)
  
• Division 041 related to Drug Outlet Requirements 
  
• Division 080 related to Schedule II Prescriptions
• Divisions 115/125 related to Pharmacist/COPT/PT Administration of Vaccines
• Division 115 related to Pharmacist Applicability, Definitions, Supervision, Counseling, PIC:Qualifications & Limitations, and CPA & CDTM
• Division 125 related to Pharmacy Technician Prohibited Practices

October 2023

The board permanently adopted the following rules at the October 2023 Board meeting:

• Division 007 related to Compliance w/OHA COVID-19 rules - Repealed  *Effective 10/17/2023
  
• Divisions 019/041/043/044/139 related to Short-acting Opioid Antagonist  *Effective 10/17/2023 
• Division 045 related to USP <795> and USP <797> Standards adopted by Reference  *Effective 10/17/2023
• Division 115 related to Short-acting Opioid Antagonist  *Effective 3/1/2024
  
  

September 27, 2023 Rulemaking Hearing

• Division 007 related to Compliance w/OHA COVID-19 rules
  
• Divisions 019/041/043/044/139 related to Short-acting Opioid Antagonist 
  
• Division 045 related to USP <795> and USP <797> Standards Adopted by Reference 
• Division 115 related to Short-acting Opioid Antagonist
  
• Divisions 115/125 related to RPH Applicability, Definitions, Counseling; COPT/PT Prohibited Practices
  

August 2023

The board permanently adopted the following rules at the August 2023 Board meeting:

• Division 102 related to Board Administration  *Effective 3/1/2024
  
• Division 104 related to Universal Rules  *Effective 3/1/2024
• Division 115 related to Pharmacists  *Effective 3/1/2024 
• Division 120 related to Interns and Preceptors  *Effective 3/1/2024 
• Division 125 related to Pharmacy Technicians  *Effective 3/1/2024
  

July 26, 2023 Rulemaking Hearing

• Division 080 related to Schedule I - Xylazine
  
• Division 102 related to Board Administration
  
• Division 104 related to Universal Rules 
  
• Division 115 related to Pharmacists
  
• Division 120 related to Interns and Preceptors
  
• Division 125 related to Pharmacy Technicians 

• Divisions 041/043/183 related to Drug Compounding  *THE BOARD DOES NOT INTEND TO ADOPT THESE RULES IN AUGUST 2023 - SEEKING PUBLIC COMMENT ONLY

June 2023

The board permanently adopted the following rules at the June 2023 Board meeting:

• Divisions 006/041/043/045/080/139/141 related to Standards Adopted by Reference  *Effective 6/13/2023
  
• Divisions 019/020 related to Pharmacist Prescriptive Authority  *Effective 6/13/2023
  
• Continuation of Therapy including Emergency Refills of Insulin v. 6/2023
  
• Travel Medications v. 6/2023
  
• HIV Post-exposure Prophylaxis (PEP) v. 6/2023 
  
• HIV Pre-exposure Prophylaxis (PrEP) v. 6/2023 
• Contraception v. 6/2023 
• Divisions 019/041/043/045/080/139/141/143 related to Annual Self-Inspection Form Completion Date *Effective 8/1/2023 
  

May 23, 2023 Rulemaking Hearing

• Divisions 006/041/043/045/080/139/141 related to Standards Adopted by Reference
  
• Divisions 019/020 related to Pharmacist Prescriptive Authority
• COVID-19 Monoclonal Antibody & COVID-19 Antiviral Protocols *Repeal 
• Continuation of Therapy including Emergency Refills of Insulin v. 6/2023 
• Travel Medications v. 6/2023
  
• HIV Post-exposure Prophylaxis (PEP) v. 6/2023
  
• HIV Pre-exposure Prophylaxis (PrEP) v. 6/2023 
• Contraception v. 6/2023
  
• Divisions 019/041/043/045/080/139/141/143 related to Self-Inspection Form Completion Date
  

April 2023 Temporary Rule Noticed

• Division 045 related to USP <795> & USP <797> Adopted Standards by Reference  *Effective 5/5/2023

February 2023

The board permanently adopted the following rules as the February 2023 Board meeting:

• Divisions 019/041 related to Safe Pharmacy Practice Conditions: RPH Autonomy, Outlet Requirements *Effective 2/14/2023
  
• Division 110 related to Pharmacy Prescription Kiosk (PPK) Registration Fee *Effective 2/15/2023
  
• Division 019 related to Definitions *Effective 2/14/2023 
  

February 2023 Temporary Rule Noticed

• Division 020 - related to Protocols for COVID-19 Monoclonal Antibody & COVID-19 Antiviral *Effective 2/10/2023
  

January 26, 2023 Rulemaking Hearing

• Divisions 019/041 related to Safe Pharmacy Practice Conditions: RPH Autonomy, Outlet Requirements 
  
• Division 110 related to Pharmacy Prescription Kiosk (PPK) Registration Fee 
  
• Division 019 related to Definitions 
  

2023 Rulemaking Hearing Videos